Vancive Medical Technologies™ and Aspen Medical Europe Ltd have announced an agreement for the exclusive distribution of the Vancive BeneHold™ Absorbent Wound Dressing portfolio in the UK and Ireland.

The BeneHold range comprises three product lines, which offers specific performance and value to clinicians and patients.

The products, which are available on the Drug Tariff from October 1 2014 are:

  • Thin Absorbent Wound Dressing featuring TASA™ (Thin Absorbent Skin Adhesive™)
  • Bordered hydrocolloid dressing with odour control, available in two advanced formulations
  • Standard hydrocolloid dressing

Vancive president and general manager Howard Kelly said: "By adding technologies like TASA and advanced hydrocolloids that complement Aspen’s portfolio of advanced wound care products, we provide a comprehensive solution to meet the needs of the practitioner."

Bordered hydrocolloid dressing with odour control is formulated with non-cytotoxic cyclodextrins, which capture odour molecules to increase patient confidence.

The dressings have a superior fluid handling capacity, compared with existing products at equivalent thickness. The thin absorbent dressings are based on Vancive’s proprietary TASA technology.

TASA dressings are 0.12mm, less than half the thickness of other ‘thin’ hydrocolloids and are conformable, transparent and provide less opportunities for the dressing’s edge to lift off of the skin.

In early evaluations of BeneHold’s absorbent wound dressings, clinicians discovered longer wear times can be achieved, especially on hard-to-dress or moisture-complicated areas.

Nurses also found them easy to work with and patients found them to be comfortable to wear and atraumatic to remove.

Aspen Medical Europe Limited sales and marketing director Chris Hill said: "The Aspen Medical team looks forward to working with Vancive and its Benehold product range to provide wound care practitioners solutions that will help them meet their clinical challenges."

The products were launched by Vancive and Aspen Medical at the Wounds UK conference in Harrogate on 10-12 November.